PIK3CA and neuroblastoma: PLK-1 [26], CDK-1 [27], PIK3CA [28], ATF4 [23], TEAD4 [29] and ALYREF [30] could enhance MYCN protein stability and sustain MYCN expression in neuroblastoma.